MedWatch

New Ambu CEO might have to hunt for more capital, says media

Britt Meelby Jensen might have to raise millions of kroner from the stock exchange if medtech firm Ambu wants to stay on top of its efforts within gastroenterology.

Britt Meelby Jensen, CEO of Ambu | Photo: Atos / PR

According to Danish business daily Børsen, Ambu’s new chief executive, Britt Meelby Jensen, might find it necessary to seek capital from the stock exchange if the firm’s current growth strategy is meant to stay on tracks.

This assessment is based on the opinions of a number of equity analysts the media has spoken with.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs